GIOVANNONI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 552
EU - Europa 246
AS - Asia 101
AF - Africa 3
OC - Oceania 3
SA - Sud America 1
Totale 906
Nazione #
US - Stati Uniti d'America 537
IT - Italia 109
SE - Svezia 55
IN - India 41
CN - Cina 33
SG - Singapore 24
DE - Germania 23
FI - Finlandia 22
BG - Bulgaria 16
CA - Canada 15
GB - Regno Unito 9
PL - Polonia 5
AU - Australia 3
FR - Francia 3
HK - Hong Kong 2
IE - Irlanda 2
TG - Togo 2
AR - Argentina 1
EG - Egitto 1
IR - Iran 1
RO - Romania 1
UA - Ucraina 1
Totale 906
Città #
Fairfield 65
Chandler 57
Ashburn 43
Rome 38
Woodbridge 31
Cambridge 26
New York 26
Seattle 25
Wilmington 25
Houston 24
Princeton 21
Plano 18
Millbury 16
Sofia 16
San Paolo di Civitate 15
Beijing 11
Dearborn 10
Singapore 10
Ann Arbor 9
Lawrence 9
Ottawa 7
Toronto 7
Andover 6
Helsinki 6
Bühl 4
Fremont 4
Hyderabad 4
Milan 4
San Diego 4
Boston 3
Bremen 3
Jinan 3
Kunming 3
London 3
Melbourne 3
Norwalk 3
Bologna 2
Capannori 2
Dublin 2
Fuzhou 2
Hong Kong 2
Liverpool 2
Lomé 2
Phoenix 2
Redmond 2
Asti 1
Aversa 1
Boardman 1
Cairo 1
Candelo 1
Castelfidardo 1
Centrale 1
Civitavecchia 1
Des Moines 1
Federal 1
Florence 1
Hebei 1
Hefei 1
Lodz 1
Mashhad 1
Monterotondo 1
Montréal 1
Nanchang 1
Nanjing 1
Napoli 1
New Delhi 1
Ningbo 1
Nürnberg 1
Piediluco 1
Polska 1
Portsmouth 1
Pune 1
Redwood City 1
San Pellegrino Terme 1
Sassuolo 1
Shanghai 1
Southend 1
Turin 1
Warsaw 1
Wenzhou 1
Wuhan 1
Totale 616
Nome #
Gemcitabine-induced extensive skin necrosis 83
BRAFV600E mutation positive metastatic melanoma in a young woman treated with anti-BRAF/anti MEK combination: a case report 81
Antiangiogenic agents are ineffective to increase complete response rate in MRCC:A meta-analysis 79
The role of systemic chemotherapy 63
Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration 63
Etoricoxib and anastrozole in adjuvant early breast cancer: ETAN trial (phase III) 60
Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II) 59
Follow-up in patients with BRCA mutations; focus on ovarian cancer risk : a single-center experience 54
Erlotinib in metastatic non-small cell lung cancer (NSCLC) patients unselected for Epidermal Growth Factor Receptors (EGFR) mutations: a retrospective analysis of elderly patients 49
Hereditary ovarian cancer 48
Il carcinoma del colon retto metastatico- Sicurezza ed efficiacia di Panitumumab dopo reazioni infusionali da Cetuximab nel carcinoma del colon retto metastatico 47
null 45
Long-lasting complete response with trabectedin plu pegylated liposomal doxorubicin (PLD) in a young BRCA-mutated woman with platinum sensitive relapsed ovarian cancer (ROC) : a case report 39
Extending the platinum-free interval (PFI) with Trabectedin plus Pegylated liposomal doxorubicin (PLD) in a patient with partially platinum sensitive (PPS) recurrent ovarian cancer. 38
Correlation between GCIG-CA125 and radiological progression in determining disease progression in patients receiving bevacizumab for advanced ovarian cancer: a retrospective study 32
Start-therapy in cancer pain management: news from the past 32
Large cell neuroendocrine carcinoma (LCNEC) of the cervix in a BRCA2 VUS carrier woman responding to PARP inhibitor: a case report 29
ENYGO Teach the Teachers & Complications in Gyneacological Oncology workshop 27
The role of systemic chemotherapy 15
Totale 943
Categoria #
all - tutte 2.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 27 5 0 7 17 22 31 19 20 12 8 3
2020/202151 14 11 5 1 1 6 2 1 6 1 1 2
2021/2022154 4 3 11 3 30 2 0 17 9 20 17 38
2022/2023229 38 34 15 15 28 24 9 17 34 1 9 5
2023/2024117 4 12 0 10 5 42 0 15 1 6 14 8
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 943